At a glance
ClinicalIndex Comparison RecordN/ACompleted· 88 enrolled
Drug / intervention
Placebo +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Confirmatory Study on the Acute Effects of Zynamite® S on Cognitive Function and Mood in University Students: a Randomized, Double-blind, Placebo-controlled Crossover Study
In Brief
A clinical study evaluating Placebo and Zynamite® S for Cognitive Performance and Mood. Completed, enrolled 88 participants across 1 site.
Detailed Summary
The present study sought to confirm the cognitive and mood benefits of a standardized soluble mango leaf extract, named as Zynamite® S. A placebo or a single dose of the botanical extract (100 mg) was administered and its acute effects on mental function and mood were evaluated before product intake, at 30 min, 3 h, and 5 h post-ingestion.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCognitive Performance, Mood
CountriesSpain
CollaboratorsUniversity of Atlántico Medio
Timeline
N/ACompletedFinished
2026
Enrollment StartMay 2025
Primary CompletionJun 2025
Study CompletionJun 2025
First PostedAug 2025
TodayJul 2026
First PostedAug 17, 2025
Enrollment StartMay 12, 2025
Primary CompletionJun 2, 2025
Study CompletionJun 9, 2025
TodayJul 2, 2026
Enrollment to primary: 20 daysPosted 11 months ago
Interventions
Placebodietary
Food-grade maltodextrin
Zynamite® Sdietary
Water-soluble mango leaf extract standardized to 60% of mangiferin